The Argentina kidney function test market is
anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for diagnostic
testing because it gives some health benefits such as early detection of
diseases, accurate diagnosis, improved patient outcome, and other personalized
medicine based on their unique genetic makeup. Also, the increasing demand for personalized
medicines and reduced healthcare costs along with the growing demand for diagnostic
testing and personal healthcare such as diagnosis of diseases, including
chronic kidney disease (CKD), acute kidney injury (AKI), and kidney stone and
nephrotic syndrome will drive the growth of the Argentina kidney function test
market during the forecast period. According to National Kidney
Foundation of Argentina, kidney disease is a significant health issue in
Argentina, with an estimated 10% of the population affected by chronic kidney
disease (CKD).
The Government of Argentina has increased its
healthcare expenditure in recent years, which has resulted in improved access
to healthcare services, including kidney function tests. Also, advancements in technology
have resulted in more accurate and efficient diagnostic tests, which, in turn,
may drive the growth of the Argentina kidney function test kit market during
the forecast period.
Rising Developments in Diagnostic Testing Methods
Rising developments in diagnostic testing methods
have a significant impact on the Argentina kidney function test market. The Argentina
kidney function test market is continuously evolving, with new diagnostic
testing methods and technologies being introduced to improve the accuracy and
efficiency of kidney function testing. Biomarker tests, which measure blood
and urine levels of specific proteins, including NGAL and Kim-1, are promising
in clinical trials as biomarkers for renal disease.
New diagnostic testing methods offer higher
accuracy, precision, and sensitivity, which enables healthcare providers to
detect kidney diseases early and provide more accurate diagnoses. Advancements
in diagnostic testing methods have also led to the development of faster and
more efficient tests, which reduce the time taken to obtain results and
increase patient throughput. Advanced diagnostic testing methods can reduce
healthcare costs by enabling earlier diagnosis and treatment of kidney
diseases, which can help to prevent complications and reduce hospitalization
costs. A basic blood test to measure creatinine and electrolyte levels may
cost around USD1.77 to USD 3.54, while a more comprehensive panel of tests,
including imaging tests and biomarker tests, can cost several USD. Accurate
and early diagnosis of kidney diseases using advanced diagnostic testing
methods helps healthcare providers to develop appropriate treatment plans and
monitor disease progression effectively.
Increasing Prevalence of Diabetes and Hypertension
Diabetes and hypertension are two of the leading
causes of chronic kidney disease (CKD) across the world. As the prevalence of
these conditions increases, the demand for kidney function testing also
increases. According to the International Diabetes Federation, an estimated
5.4 million people in Argentina had diabetes in 2019, which represents a
prevalence of 10.4% of the population. In addition, according to the World
Health Organization, hypertension affects about 33% of adults in Argentina,
which represents more than 12 million people.
Diabetes can damage the kidneys over time, leading
to CKD and eventually to end-stage renal disease (ESRD) if left untreated.
Hypertension can also cause damage to the blood vessels in the kidneys, leading
to CKD and ESRD. In both cases, early detection and management of kidney
disease through regular kidney function testing can help to slow the
progression of the disease and prevent or delay the need for more expensive and
invasive treatments such as dialysis or kidney transplantation. According to
a study published in the journal PLOS ONE in 2019, about 49% of people with
diabetes in Argentina were undiagnosed.
The increasing prevalence of diabetes and
hypertension in Argentina is driving the demand for kidney function testing in
several ways. Routine kidney function testing is recommended for people with
diabetes and hypertension to detect any signs of kidney damage at an early stage.
As the population ages, the prevalence of diabetes and hypertension increases,
leading to a higher demand for kidney function testing among older adults. Such
factors will drive the growth of the Argentina kidney function test market
during the forecast period.
Increasing Number of Private Hospitals And Clinics
The increase in the number of private hospitals and
clinics in Argentina has been a significant driver of the kidney function test
market in the country. Private hospitals and clinics often have more resources
and advanced diagnostic technologies than public healthcare facilities, which
allows them to offer a wider range of diagnostic tests, including kidney
function tests. According to the World Health Organization (WHO), Argentina
had a total of 8,165 health facilities, including hospitals and clinics, in
2018. The private sector accounted for 52.5% of all health facilities in the
country, while the public sector accounted for 47.5% As the number of private
hospitals increases becomes more accessible to people for kidney function test
due to which it anticipates the growth of Argentina Kidney Function Test Market
As the demand for high-quality healthcare services
in Argentina has increased in recent years, the number of private hospitals and
clinics has also grown, particularly in urban areas. Private healthcare
providers are often able to offer faster and more efficient services than
public healthcare facilities, which can be especially important for patients
with kidney disease who require regular monitoring and testing. According to
a report by the Organization for Economic Co-operation and Development (OECD)
published in 2019, the rise in the number of private hospitals and clinics
increased competition in the healthcare sector, leading to more innovation and
investment in new technologies and services. This has resulted in the
development of new and more advanced kidney function testing methods, which has
further driven the growth of the Argentina kidney function test market.
Download Free Sample Report
Recent Developments
In November 2020, DiaSys Diagnostic Systems GmbH, a
global leader in clinical diagnostics, announced that it had signed a
distribution agreement with RAL Group, a prominent distributor of medical
equipment in Argentina, to expand its presence in the country's kidney function
test market.
In February 2021, Werfen, a leading global
healthcare company, completed the acquisition of Accriva Diagnostics, a
provider of point-of-care testing solutions, including tests for kidney
function, among others.
In September 2021, Siemens Healthineers, a global
medical technology company, announced that it had completed the acquisition of
Varian Medical Systems' medical imaging business, including its magnetic
resonance imaging (MRI) technology, which has the potential to improve the
accuracy of kidney function testing.
Market Segmentation
The Argentina kidney function test market can be segmented
by type, component, end user, and region. Based on type, the market can be segmented
into urine test and blood test. Based on component,
the market can be segmented into dipsticks, reagents, kits & assays, and
others. Based on end user, the market can be grouped into hospitals & clinics, diagnostics laboratories, and
others.
Market Players
Abbott Laboratories Argentina S.A., Roche
Diagnostics Argentina S.A., Siemens Healthcare Diagnostics S.A., Beckman
Coulter Argentina S.A., Bio-Rad Laboratories S.A., Sysmex Argentina S.A.,
Mindray Argentina S.A., Horiba Medical Argentina S.A., F. Hoffmann-La Roche
Ltd., and Danaher Corporation/Argentina are some of the leading players
operating in the Argentina kidney function test market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report Coverage
|
Revenue forecast, company
share, competitive landscape, growth factors, and trends
|
|
Segments Covered
|
Type
Component
End User
|
|
Regional scope
|
Pampas, Litoral, Northwest,
Sierras, and Cuyo
|
|
Key companies profiled
|
Abbott Laboratories Argentina S.A., Roche Diagnostics Argentina S.A.,
Siemens Healthcare Diagnostics S.A., Beckman Coulter Argentina S.A., Bio-Rad
Laboratories S.A., Sysmex Argentina S.A., Mindray Argentina S.A., Horiba
Medical Argentina S.A., F. Hoffmann-La Roche Ltd., Danaher
Corporation/Argentina
|
|
Customization scope
|
10% free report customization
with purchase. Addition or alteration to country, regional & segment
scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore
purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We
can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, the Argentina kidney function test market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- Argentina Kidney Function Test
Market, By Type:
o Urine Test
o Blood Test
- Argentina Kidney Function
Test Market, By Component:
o Dipsticks
o Reagents
o Kits & Assays
o Others
- Argentina Kidney Function
Test Market, By End User:
o
Hospitals
& Clinics
o
Diagnostics
Laboratories
o
Others
- Argentina Kidney Function
Test Market, By Region:
o
Pampas
o
Litoral
o
Northwest
o
Sierras
o
Cuyo
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the Argentina kidney function test market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Argentina kidney function test market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]